.ANALYSIS FEATURE.06 August 2024.
A sizable randomized measured trial with cisgender females highlights the obstacles of adherence to an everyday dental preexposure prevention routine as well as demonstrates that twice-yearly shot of lenacapavir may maintain successful HIV prevention levels over 6 months.